Bunge Global SA 8-K filings

Bunge has extended the expiration date for its exchange offers and consent solicitations related to Viterra's existing notes, as it works towards completing the acquisition of Viterra.

Bunge has extended the expiration date for its exchange offers and consent solicitations related to Viterra's debt, as the company progresses towards its acquisition of Viterra.

Bunge Global SA amended its Articles of Association to reflect a reduction in share capital due to the cancellation of repurchased shares.

Bunge Global SA has amended its trade receivables securitization program, extending the termination date by 364 days to December 16, 2025.

Bunge Global SA has increased its share repurchase program by $500 million, bringing the total authorization to approximately $1.3 billion.

Bunge has extended the expiration date for its exchange offers and consent solicitations related to Viterra's debt, pushing the deadline to January 2, 2025, as it works towards completing the acquisition of Viterra.

Bunge Global SA announced its third quarter 2024 results, showing a decrease in earnings per share compared to the previous year, despite solid performances in Agribusiness and Refined and Specialty Oils.

Bunge has extended the expiration date for its exchange offers and consent solicitations related to Viterra's existing notes, as it works towards completing the acquisition of Viterra.

Bunge Global SA has finalized the sale of its 50% ownership in the BP Bunge Bioenergia joint venture to BP for approximately $828 million.

Bunge's subsidiary, BLFC, has received overwhelming early support for its exchange offers and consent solicitations related to Viterra notes, paving the way for the removal of certain guarantees and covenants.

Bunge Global SA's finance subsidiary has successfully completed a $2 billion offering of senior notes to partially fund its acquisition of Viterra Limited and repay related debt.

Bunge Global SA's finance subsidiary has priced a $2 billion senior notes offering to help fund the acquisition of Viterra Limited and repay related debt.

Bunge's subsidiary, BLFC, has initiated exchange offers for Viterra's existing notes, totaling up to $1.95 billion, as part of the pending acquisition of Viterra Limited.

Bunge Global SA files a Form 8-K including audited financials for Viterra as part of its acquisition process.

Bunge Global SA announced its second quarter 2024 results, showing a decrease in earnings per share compared to the previous year, alongside progress on strategic initiatives.

Bunge Global SA will sell its 50% stake in the BP Bunge Bioenergia joint venture for approximately $800 million, as it focuses on core businesses.

Bunge Global SA's shareholders approved the company's 2024 Long-Term Incentive Plan and re-elected ten directors at the 2024 Annual General Meeting.

Bunge's first quarter 2024 results show a decrease in GAAP earnings per share compared to the previous year, though the company maintains its full-year adjusted EPS outlook.

Bunge Limited Finance Corp., a subsidiary of Bunge Global SA, amended its $1.1 billion revolving credit agreement and increased its commercial paper program to $2.0 billion.

Bunge and Repsol have formed a partnership in Spain, with Repsol acquiring a 40% stake in Bunge's Spanish operations for $300 million, to accelerate the production of renewable fuels.

Bunge Global SA's subsidiary, Bunge Limited Finance Corp., has entered into a new $3.2 billion revolving credit agreement, while Bunge Finance Europe B.V. has increased its existing credit facility by $1.75 billion.

Bunge Global SA announced robust financial results for the fourth quarter and full year of 2023, driven by strong execution across its value chains.